focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks recover into end of week as airlines rise

Fri, 09th Jul 2021 08:42

(Alliance News) - London stocks were heading for a smoother end to a rocky week, with M&A activity and rising travel stocks helping to lift the mood in early dealings on Friday.

The FTSE 100 index was up 25.67 points, or 0.4%, at 7,056.33 early Friday. The mid-cap FTSE 250 index was up 100.13 points, or 0.4%, at 22,752.85. The AIM All-Share index was 0.1% higher at 1,249.30.

The Cboe UK 100 index was up 0.4% at 702.30. The Cboe 250 was 0.4% higher at 20,461.88, and the Cboe Small Companies up 0.1% at 15,414.13.

In mainland Europe, the CAC 40 in Paris was up 0.9% while the DAX 30 in Frankfurt gained 0.6% early Friday.

European markets were rebounding after sell-offs on Thursday, which saw the FTSE 100 plummet 1.7%.

"With increasing concern that the Delta variant (or indeed other variants) of the coronavirus will delay the forecast strengthening of economies over the second half of this year – a concern flagged yesterday by the San Francisco Fed's Mary Daly – risk aversion dominated yesterday's trading," said Daiwa Capital Markets.

The mood was largely downbeat in Asia on Friday. The Japanese Nikkei 225 index closed down 0.6%. In China, the Shanghai Composite closed flat, while the Hang Seng index in Hong Kong was up 0.9%, after diving 2.9% on Thursday. The S&P/ASX 200 in Sydney ended down 0.9%.

However, London stocks opened on the front foot, lifted by airline stocks.

Travel firms rose as people rushed to book summer getaways following the government's announcement that UK holidaymakers who have received two jabs from the NHS will no longer be required to self-isolate for 10 days on their return to England from destinations on the amber list.

Tourist hotspots such as Greece, France and Italy are currently on the UK government's amber list.

Travel firm Skyscanner said 30 minutes after the announcement, the agency saw a 53% increase in traffic from the UK compared to the same time on Wednesday. Thomas Cook said web traffic doubled in the moments after the announcement, and has only grown since.

British Airways parent International Consolidated Airlines rose 2.0% and mid-cap easyJet advanced 2.7%.

Bunzl was up 3.0%, sat atop the FTSE 100, after Berenberg raised the distribution and services stock to Buy from Hold.

Luxury fashion retailer Burberry rose 2.4% as it also got a boost from a ratings upgrade, with Goldman Sachs raising the trenchcoat maker to Buy from Neutral.

Vectura topped the FTSE 250, up 12% at 152.40 pence after agreeing to be taken over Marlboro cigarette maker Philip Morris International.

Philip Morris will pay 150p per share in cash for Vectura, a Wiltshire, England-based inhaled drug delivery devices maker. Including a 19p interim dividend, the deal values the FTSE 250 constituent at GBP1.04 billion.

Following the PMI offer, Vectura's directors withdrew their recommendation for a GBP958 million takeover by funds managed by private equity firm Carlyle Group. PMI's offer is a 10% premium to Carlyle's 136p per share bid.

However, with Vectura trading above PMI's offer price early Friday, investors could be anticipating a bidding war.

"PMI is expanding into products beyond tobacco and nicotine, as part of a natural evolution into a broader healthcare and wellness company," the New York-based company said.

Victrex edged up 1.0% as it saw upside risk to current full-year expectations, but warned of headwinds for the 2022 financial year.

The polymer supplier said it is seeing continued momentum in most end markets and posted 37% growth in third quarter revenue to GBP80.7 million, with sales volumes of 1,202 tonnes up 49% year-on-year.

On a year-to-date basis, being the nine months to June 30, revenue was up 10% year-on-year at GBP231.6 million.

"Reflecting the volume strength on a year to date basis, we now see the potential for some upside to current full year expectations, with our internal assumptions being closer to the upper end of market expectations," said Chief Executive Jakob Sigurdsson.

However, he noted that for the 2022 financial year, Victrex will have to contend with foreign currency headwinds, increasing raw material inflation, an anticipated uplift in innovation spend to support the long-term growth pipeline, and some costs associated with commissioning its China manufacturing facility.

"These effects will weigh on our 2022 prospects, although we remain focused on growth," said Sigurdsson.

In currency markets, the pound was clawing back some gains after a weaker-than-expected UK gross domestic product reading.

UK GDP grew 0.8% in May from April, missing forecasts for a stronger monthly gain of 1.7%, according to FXStreet, and below April's growth of 2.0%, which itself was revised down from 2.3%. The economy remains 3.1% below its pre-virus levels, the ONS said.

Sterling was trading at USD1.3773, up from USD1.3763 at the London equities close on Thursday.

The euro traded at USD1.1835 early Friday, down from USD1.1842 late Thursday. Against the yen, the dollar rose to JPY110.06 versus JPY109.79.

Gold was quoted at USD1,804.17 an ounce early Friday, higher than USD1,796.50 on Thursday. Brent oil was trading at USD74.50 a barrel, up from USD73.70 late Thursday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 May 2020 13:10

UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease

UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease

Read more
1 May 2020 14:30

Vectura upbeat on EMA nod for 'Enerzair Breezhaler'

(Sharecast News) - Inhalation contract manufacturer Vectura Group noted an announcement from Novartis on Friday, that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of 'Enerzair Breezhaler'.

Read more
23 Mar 2020 09:43

UK BROKER RATINGS SUMMARY: Barclays Raises Pearson, Moneysupermarket

UK BROKER RATINGS SUMMARY: Barclays Raises Pearson, Moneysupermarket

Read more
17 Mar 2020 12:31

Vectura Resilient Against Covid-19 As Flutiform Drives Annual Growth

Vectura Resilient Against Covid-19 As Flutiform Drives Annual Growth

Read more
10 Mar 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Jan 2020 09:36

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

Read more
21 Jan 2020 12:48

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Read more
13 Jan 2020 09:19

Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On

Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On

Read more
13 Jan 2020 08:25

Vectura sees FY revenues and earnings 'at least' in line with expectations

(Sharecast News) - Pharmaceuticals company Vectura said on Monday that its base business had continued to perform well in 2019.

Read more
27 Nov 2019 08:26

TOP NEWS: Hikma Submits Response To Advair Application Deficiencies

TOP NEWS: Hikma Submits Response To Advair Application Deficiencies

Read more
29 Oct 2019 09:41

Vectura Group Hires Former GE Healthcare Exec Will Downie As New CEO

Vectura Group Hires Former GE Healthcare Exec Will Downie As New CEO

Read more
18 Oct 2019 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
4 Oct 2019 17:31

UPDATE 1-Vectura, Sandoz win ruling on inhaler packaging case against GSK

(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...

Read more
4 Oct 2019 14:24

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

Read more
3 Oct 2019 16:04

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.